Indications and dosage
Varilrix is indicated for active immunisation against varicella of healthy subjects (from the age of 9 months).
Vaccination of susceptible healthy close contacts of subjects at risk of severe varicella is recommended, in order to reduce the risk of transmission of wild-type virus to these patients. Close contacts include parents and siblings of high-risk patients, and medical and paramedical personnel.
Posology and Method of Administration
Children 9 months up to and including 12 years
Two doses (each of 0.5 ml of reconstituted vaccine) should be given to ensure optimal protection against varicella (see section 5.1).
- Children from 9 to 12 months of age
The second dose should be given after a minimum interval of 3 months.
- Children from 12 months to 12 years of age
The second dose should be given after an interval of at least 6 weeks but in no circumstances less than 4 weeks.
Varilrix should not be administered to children aged less than 9 months.
Adolescents and adults from 13 years of age and above
Two doses (each of 0.5 ml of reconstituted vaccine). It is preferable to administer the second dose at least 6 weeks after the first dose but in no circumstances less than 4 weeks.
There are no data on immune responses to Varilrix in the elderly.
A single dose of Varilrix may be administered after a first dose of another varicella containing vaccine (see section 5.1).
A single dose of Varilrix may be administered followed by a single dose of another varicella-containing vaccine.